Filana Therapeutics, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Filana Therapeutics, Inc. (FLNA) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $3.45 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-03.
Discontinued › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2016-03-03
- Filana Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2015 was $3.45M, a 4.59% decline from fiscal 2014.
- Filana Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2014 was $3.62M, a 20.39% increase from fiscal 2013.
- Filana Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2013 was $3.01M, a 54.00% decline from fiscal 2012.
- Filana Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2012 was $6.54M, a 21.51% increase from fiscal 2011.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|
| 2015-12-31 | $3.45M 10-K · filed 2016-03-03 |
| 2014-12-31 | $3.62M 10-K · filed 2016-03-03 |
| 2013-12-31 | $3.01M 10-K · filed 2014-02-05 |
| 2012-12-31 | $6.54M 10-K · filed 2014-02-05 |
| 2011-12-31 | $5.38M 10-K · filed 2014-02-05 |
| 2010-12-31 | $20.10M 10-K · filed 2013-02-08 |
| 2009-12-31 | $6.68M 10-K · filed 2012-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |